NBIX
NEUROCRINE BIOSCIENCES INC
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Operating Income
$619.1M
↑ 8.5%
Net Income
$478.6M
↑ 40.2%
Total Assets
$4.6B
↑ 24.5%
Revenue
$2.9B
↑ 21.4%
Total Liabilities
$1.4B
↑ 22.1%
EPS (Diluted)
$4.67
↑ 41.9%
Cash & Equivalents
$713.0M
↑ 206.0%
Shareholders' Equity
$3.3B
↑ 25.6%

Recent SEC Filings

Form Type Filed Date Link
ARS 4/15/2026 View on SEC
DEFA14A 4/15/2026 View on SEC
DEF 14A 4/15/2026 View on SEC
SC TO-C 4/7/2026 View on SEC
SC TO-C 4/6/2026 View on SEC
SC TO-C 4/6/2026 View on SEC
8-K 4/6/2026 View on SEC
SCHEDULE 13G/A 3/27/2026 View on SEC
3 3/17/2026 View on SEC
4 3/5/2026 View on SEC

Company Information

Field Value
Ticker NBIX
Company Name NEUROCRINE BIOSCIENCES INC
CIK 914475
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (858) 617-7600